Drug Type Interferons, Biosimilar |
Synonyms IFN-γ-1a, Imunomax, Interferon gamma 1a biosimilar + [3] |
Target |
Action stimulants |
Mechanism IFNGR stimulants(Interferon gamma receptor stimulants), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (29 Sep 1989), |
RegulationOrphan Drug (Japan) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Sezary Syndrome | Japan | 23 May 2014 | |
Granulomatous Disease, Chronic | Japan | 30 Jun 1998 | |
Kidney Neoplasms | Japan | 29 Sep 1989 |